#SFHS2610168VNotice Regarding Pharmaceutical Specialty Prices
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice outlines the new prices for certain pharmaceutical products, effective from April 15, 2026, focusing on the drug Apremilast in various dosages and package types. It mainly impacts pharmaceutical companies and possibly healthcare providers who purchase these medications.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- New prices set for Apremilast pharmaceutical products starting April 15, 2026
- Prices specified for different dosages and package types
- Applies to products from Laboratoires KRKA France
Obligations
What this law requires
Apply the price of 99,86 € (PPTTC) to APREMILAST HCS 10/20/30 mg initiation pack (27 tablets) with CIP 34009 303 070 8 starting April 15, 2026
Apply the price of 205,86 € (PPTTC) to APREMILAST HCS 30 mg tablets (box of 56) with CIP 34009 303 071 0 starting April 15, 2026
Apply the wholesale price (PFHT) of 82,94 € to APREMILAST HCS initiation pack (27 tablets) starting April 15, 2026
Apply the wholesale price (PFHT) of 172,03 € to APREMILAST HCS 30 mg tablets (box of 56) starting April 15, 2026